Response to Dr. Wee
Pain Med
.
2020 Oct 1;21(10):2604.
doi: 10.1093/pm/pnaa056.
Authors
Stefano Jann
1
,
Raffaella Fazio
2
,
Dario Cocito
3
,
Antonio Toscano
4
,
Angelo Schenone
5
,
Gerolama Alessandra Marfia
6
,
Giovanni Antonini
7
,
Luisa De Toni Franceschini
8
,
Anna Mazzeo
4
,
Marina Grandis
5
,
Daniele Velardo
2
,
Giorgia Mataluni
6
,
Erdita Peci
3
Affiliations
1
Department of Neurology, Niguarda General Hospital, Milan, Italy.
2
Department of Neuromuscular Disease, San Raffaele Hospital, Milan, Italy.
3
Department of Neuroscience, University of Turin, Torino, Italy.
4
Department of Neuroscience, Psychiatry and Anesthesiology, University of Messina, Messina, Italy.
5
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy.
6
Department of Neuroscience, University Tor Vergata, Rome, Italy.
7
Department of Neuroscience, Mental Health and Sensory Organs, Rome University "Sapienza", Sant'Andrea Hospital, Rome, Italy.
8
Department of Neurology, Alesssandro Manzoni General Hospital, Lecco, Italy.
PMID:
32457998
DOI:
10.1093/pm/pnaa056
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetes Mellitus*
Diabetic Neuropathies*
Double-Blind Method
Humans
Immunoglobulins, Intravenous
Substances
Immunoglobulins, Intravenous